1/2

Export Ready

Recombinant human erythropoietin injection

Name: Recombinant human erythropoietin injection
SKU: 8485207
Availability: InStoreOnly

Sold by ayursatva pharma llp · Raigad, Maharashtra, India

Price

Price on request

In stock

Inclusive of all taxes

Minimum order: 1 Centimetre

Export Snapshot

MOQ

1 Centimetre

Lead time

On request

Packaging

Standard export packaging

Shelf life / longevity

As per product specification

HS Code

On request

Origin

India

Port of dispatch

On request

Export markets served

Global markets

Values shown are for ayursatva pharma llp.

Compliance & Certifications

Suitable for

Importers · Distributors · Wholesalers

Raigad Dispatch on request Verified seller

ayursatva pharma llp

Verified seller · Raigad, Maharashtra, India

Registered address: RAIGAD, India.

View profile All products

Established

Not shared

Employees

–

GST

27ACGFA6465R1ZM

IEC code

Not shared

Export markets

Global markets

GlobalLinker Member Since

Not shared

Turnover

Incorporation Type

On request

Verified Seller

Product details

What are the specifications of this product?

Overview

Recombinant Human Erythropoietin Alfa is used in the treatment of anemia due to chronic kidney disease and anemia due to chemotherapy.

Product Description

Recombinant Human Erythropoietin Alfa is used in the treatment of anemia due to chronic kidney disease and anemia due to chemotherapy.

Description provided by ayursatva pharma llp.

Specifications

Molecular Type	Recombinant glycoprotein
Concentration	Variable depending on vial strength, commonly 2000 IU/ml to 40,000 IU/ml
pH Range	Approximately 6.8 to 7.5
Packaging Size	1 ml, 1.5 ml or 10 ml vials or pre-filled syringes
Preservatives	Typically preservative-free or with minimal preservative suitable for injection
Manufacturing Compliance	Produced in GMP-certified facilities
Storage Temperature	2°C to 8°C (Refrigerated)
Shelf Life	24 months from the date of manufacture
Compatibility	Compatible with intravenous and subcutaneous administration
Regulatory Approval	Complies with CDSCO guidelines for biopharmaceutical injections

Use cases

Category	Pharmaceuticals > Biopharmaceuticals > Injectable Biologics > Recombinant Hormones > Erythropoietin Injections
Primary application	Wholesale, distribution, and international sourcing
Brand	Not specified
Product type	Product

Logistics & handling

Lead time	On request
Packaging	As per buyer requirement
Storage condition	As recommended by supplier
Origin	India
Form	As listed by supplier

Commercials (this seller)

Minimum order	1 Centimetre
Lead time	On request
Payment terms	As per negotiated commercial agreement.
Checkout type	enquiry

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing Recombinant human erythropoietin injection. Answers compiled from verified sellers' commercial terms and platform data.

Q: What are the primary clinical indications for Recombinant Human Erythropoietin Alfa Injection?

A: This injection is primarily indicated for treating anemia due to chronic kidney disease and chemotherapy-induced anemia.

Q: What is the recommended route of administration for this erythropoietin alfa injection?

A: The injection is administered either intravenously or subcutaneously as prescribed by the healthcare provider.

Q: How should the Recombinant Human Erythropoietin Alfa Injection be stored?

A: It should be stored refrigerated between 2°C to 8°C and protected from freezing.

Q: Does this product require any special certifications for sale in India?

A: Yes, it complies with CDSCO guidelines and must be manufactured in GMP-certified facilities with valid regulatory approvals.

Q: What are the typical vial strengths available for this erythropoietin injection?

A: The injection is commonly available in concentrations ranging from 2000 IU/ml up to 40,000 IU/ml in various vial or pre-filled syringe sizes.

Question not answered? Ask sellers directly — typical response within 4 hours.